CAS: 1868135-06-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Sofosbuvir-d6 REF: 4Z-S-055085CAS: 1868135-06-1 | - - - | To inquire | Mon 10 Mar 25 |
 | PSI-7977-d6 REF: TR-P839644CAS: 1868135-06-1 | - - - | 3,919.00 € | Fri 11 Apr 25 |
 | Sofosbuvir d6 REF: 3D-TZC13506CAS: 1868135-06-1 | Min. 95% | To inquire | Mon 14 Apr 25 |
Ref: 4Z-S-055085
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
PSI-7977-d6
Controlled ProductCAS:1868135-06-1
Applications Isotope labelled PSI-7977 (P839640), a prodrug that is metabolized to the active antiviral agent …
Formula:
C22D6H23FN3O9P
Color and Shape:
Neat
Molecular weight:
535.49
Ref: TR-P839644
| 10mg | 3,919.00 € |
Estimated delivery in United States, on Friday 11 Apr 2025
Sofosbuvir d6
CAS:1868135-06-1
Sofosbuvir d6 is an analog of Sofosbuvir, a medication used to treat chronic hepatitis C. …
Formula:
C22H29FN3O9P
Purity:
Min. 95%
Molecular weight:
535.5 g/mol
Ref: 3D-TZC13506
| 5mg | 1,974.00 € | ||
| 10mg | 3,157.00 € | ||
| 25mg | 5,920.00 € | ||
| 50mg | 9,471.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
